BURLINGTON, Mass., Jan. 6, 2009 -- (HSMN NewsFeed) -- LeMaitre Vascular, Inc. (NasdaqGM:LMAT ) today announced the publication of a study in the Journal of Endovascular Therapy confirming the use of LeMaitre's endovascular thoracic stent graft in the treatment of thoracic aortic aneurysms and dissections. The two-year study was conducted by Lefeng Qu, MD and Dieter Raithel, MD of Nuremberg Southern Hospital.
LeMaitre Vascular's EndoFit Thoracic Stent Graft demonstrated 100% technical success in the study, a retrospective review of 87 patients undergoing endovascular repair of their thoracic aorta. There were no device- or aneurysm-related deaths and there was only a low incidence of device- or aneurysm-related complications.
Full text >>
Sunday, January 11, 2009
Two-Year Study Confirms Use of LeMaitre Vascular's Endovascular Stent Graft to Treat Thoracic Aortic Disease
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment